Liraglutide

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Liraglutide
Liraglutide.png
NMR structure of liraglutide. PDB entry 4apd
Clinical data
Trade namesVictoza, Saxenda
License data
Pregnancy
category
  • AU: B3
  • US: C (Risk not ruled out)
Routes of
administration
subcutaneous
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
ECHA InfoCard100.241.015 Edit this at Wikidata
Chemical and physical data
FormulaC172H265N43O51
Molar mass3751.202 g/mol
3D model (JSmol)

Liraglutide (marketed with brand name Victoza) is a Type 2 diabetes medication. It is a long-acting glucagon like peptide-1 agonist. It was approved by the Food and Drug Administration in early 2010.

This medication is a once daily treatment of Type 2 diabetes.